MedVi vs Brello: Semaglutide access, pricing, and process compared
MedVi vs Brello is a comparison of two online weight-management options where MedVi has clear published offers and Brello’s specifics were not verifiable from the captured landing page. Early verdict: MedVi shows a promotional first month starting at $179 with no clinic visits and 24/7 certified medical support, while Brello’s pricing, eligibility, and terms were not verified and should be confirmed before enrollment.
See MedVi promo and program details
How they differ: Pricing transparency and promotional structure
MedVi publishes a winter promotional first-month price of $179 including fast, free shipping, then lists a standalone month at $299 and a three-month plan at $649 (about $216/month). Brello’s pricing details captured on the affiliate landing page were not verified. That makes MedVi the clearer option for shoppers who prioritize a documented introductory price. If you consider ongoing cost, MedVi warns the ongoing rate is substantially higher than the promo.
Check Brello eligibility and live offer
Process and clinical access: telehealth, visits, and clinician review
MedVi offers a fully online intake with no clinic visits required; licensed clinicians review each case and determine eligibility, with OpenLoop Health clinicians retaining prescription discretion. Brello’s captured page notes treatment is available only when a licensed clinician determines it is medically appropriate, but many operational details were not verified on the captured affiliate page. Both platforms require clinician review before medication is prescribed, but MedVi’s no-clinic process and explicit online workflow are documented in the source.
Medication type and regulatory notes
MedVi markets clinically dosed compounded semaglutide and explicitly states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The source also notes compounded GLP-1s are produced in FDA-regulated facilities but are not FDA-evaluated. For Brello the captured landing-page evidence only includes a note that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both providers require confirmation of medication-specific approval status where relevant.
Support, outcomes language, and claims
MedVi advertises 24/7 support from certified medical professionals and references patient-reported averages and program-specific outcome language with multiple qualifiers, including that results vary and prescriptions are at clinician discretion. Brello captured no verified short or long bullets and no expanded FAQ content on the landing page, so outcome and support claims were not published in the captured evidence and should be confirmed directly with Brello.
Distinctive differences at a glance
| Criteria | MedVi | Brello |
|---|---|---|
| Published starting price | $179 first month promo; $299 standalone month; three-month plan $649 | Not verified on captured landing page |
| Medication offered | Clinically dosed compounded semaglutide | Not published or could not be verified |
| Clinic visits required | No clinic visits required; online intake and clinician review | Treatment only if licensed clinician determines appropriate; other details not verified |
| Support | 24/7 support from certified medical professionals | Not verified on captured page |
| Regulatory note | Compounded meds are not FDA-approved and not FDA-reviewed for safety or efficacy | Compounded medications, when offered, are not FDA-approved and are not FDA-reviewed |
Price and commitment mechanics
MedVi discloses the promotional structure and examples of ongoing pricing and a three-month offer. The source emphasizes that ongoing price is higher than the first-month promo and suggests comparing flat-rate platforms for different pricing models. For Brello the captured affiliate page did not verify pricing, renewal terms, state coverage, or pharmacy details and notes these items may change, so confirm live terms with Brello before enrolling.
View MedVi pricing and plan options
What to confirm before you enroll
With MedVi verify whether compounded semaglutide is appropriate for you and note the clinician review and the regulatory qualifiers about compounded medicines. With Brello confirm live pricing, eligibility, pharmacy, state coverage and renewal terms because these were not verified on the captured landing page.
Verify Brello live offer and state availability
Conclusion: MedVi vs Brello
MedVi vs Brello shows MedVi as the more transparent option in the captured evidence, with a published $179 promotional first month, a documented online no-clinic process, and 24/7 certified medical support. Brello’s captured affiliate landing page lacked verified pricing and most operational details, so prospective patients should confirm eligibility, medication type, total cost, renewal terms and state availability with Brello directly.
Choose MedVi if you want a documented promotional first month at $179, a fully online intake with no clinic visits, and 24/7 certified medical support, understanding compounded semaglutide is not FDA-approved.
Choose Brello if you will confirm eligibility, medication, total cost, renewal terms and state availability with the live offer before enrolling, because those details were not verified on the captured page.